» Articles » PMID: 24025621

Frozen Section Analysis and Sentinel Lymph Node Biopsy in Well Differentiated Thyroid Cancer

Overview
Publisher Sage Publications
Date 2013 Sep 13
PMID 24025621
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of this study is to prospectively review the role of sentinel lymph node (SLN) biopsy in the management of well differentiated thyroid carcinoma (WDTC), and to determine the efficacy of intraoperative frozen section analysis at detecting SLN metastasis and central compartment involvement.

Methods: The SLN biopsy protocol using 1% methylene blue was performed in 300 patients undergoing thyroidectomy for WDTC. A limited pretracheal central compartment neck dissection (CCND) was performed on all patients. Lymph nodes staining blue were considered as SLN's. Both frozen and permanent section analyses were performed.

Results: SLN's with metastasis were found in 14.3% (43/300) of cases. Of this, 11% (33/300) were positive on intraoperative frozen section analysis. Frozen section results failed in predicting central compartment involvement in 15 cases (5%) whereas central neck compartment involvement was missed in 5 cases (1.7%) when based on permanent section results. On frozen section analysis, the sensitivity, specificity, positive predictive value and negative predictive value (95% CI) of our SLN biopsy technique aiming to remove all disease from the central compartment was 68.8% (53.6-80.9), 100% (98.1-100), 100% (87.0-100) and 94.4% (90.7-96.7) respectively with P < 0.0001. On permanent section analysis, the values were 89.6% (76.6-96.1), 100% (98.1-100), 100% (89.8-100), and 98.1% (95.3-99.3) with P < 0.0001.

Conclusion: This data series demonstrates that patients with WDTC have positive SLN's in 14.3% of cases. Moreover, when the SLN's are negative for metastasis on frozen section, the central compartment was disease-free in 94.4% of cases. Finally, this study shows that 23.3% of positive SLN's were false negatives on intraoperative frozen section. According to this data, SLN involvement is an accurate predictor of central compartment metastasis, however surgeons should use caution when relying on intraoperative frozen section to determine whether to perform a CCND.

Citing Articles

The diagnosis and management of small and indeterminate lymph nodes in papillary thyroid cancer: preoperatively and intraoperatively.

Hu A, Tian J, Deng X, Wang Z, Li Y, Wang J Front Endocrinol (Lausanne). 2024; 15:1484838.

PMID: 39610843 PMC: 11602296. DOI: 10.3389/fendo.2024.1484838.


Sentinel lymph node mapping: current applications and future perspectives in thyroid carcinoma.

Merante Boschin I, Bertazza L, Scaroni C, Mian C, Pelizzo M Front Med (Lausanne). 2023; 10:1231566.

PMID: 37942415 PMC: 10629113. DOI: 10.3389/fmed.2023.1231566.


Sentinel lymph node detection in thyroid carcinoma using [Ga]Ga-tilmanocept PET/CT: a proof-of-concept study.

de Vries L, Lodewijk L, Ververs T, Poot A, van Rooij R, Brosens L Eur J Nucl Med Mol Imaging. 2023; 51(2):512-520.

PMID: 37773437 PMC: 10774182. DOI: 10.1007/s00259-023-06449-0.


The Diagnostic Accuracy of One-Step Nucleic Acid Amplification for Lymph Node Metastases of Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.

Wang X, Zheng X, Zhu J, Li Z, Wei T Front Endocrinol (Lausanne). 2022; 12:757766.

PMID: 35058876 PMC: 8764176. DOI: 10.3389/fendo.2021.757766.


[Clinical feasibility of imaging with indocyanine green combined with methylene blue for sentinel lymph node identification in papillary thyroid microcarcinoma].

Wang B, Yao T, Zhou R, Li X Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021; 35(6):543-547.

PMID: 34304516 PMC: 10128596. DOI: 10.13201/j.issn.2096-7993.2021.06.013.


References
1.
Pelizzo M, Boschin I, Toniato A, Bernante P, Piotto A, Rinaldo A . The sentinel node procedure with Patent Blue V dye in the surgical treatment of papillary thyroid carcinoma. Acta Otolaryngol. 2001; 121(3):421-4. DOI: 10.1080/000164801300103012. View

2.
Stoeckli S, Pfaltz M, Steinert H, Schmid S . Sentinel lymph node biopsy in thyroid tumors: a pilot study. Eur Arch Otorhinolaryngol. 2003; 260(7):364-8. DOI: 10.1007/s00405-003-0594-y. View

3.
Makar A, Scheistroen M, Van den Weyngaert D, Trope C . Surgical management of stage I and II vulvar cancer: the role of the sentinel node biopsy. Review of literature. Int J Gynecol Cancer. 2001; 11(4):255-62. DOI: 10.1046/j.1525-1438.2001.011004255.x. View

4.
Pereira J, Jimeno J, Miquel J, Iglesias M, Munne A, Sancho J . Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery. 2005; 138(6):1095-100, discussion 1100-1. DOI: 10.1016/j.surg.2005.09.013. View

5.
Cunningham D, Yao K, Turner R, Singer F, Van Herle A, Giuliano A . Sentinel lymph node biopsy for papillary thyroid cancer: 12 years of experience at a single institution. Ann Surg Oncol. 2010; 17(11):2970-5. DOI: 10.1245/s10434-010-1141-x. View